Deferiprone Lipomed European Union - English - EMA (European Medicines Agency)

deferiprone lipomed

lipomed gmbh - deferiprone - iron overload; beta-thalassemia - all other therapeutic products - deferiprone lipomed monotherapy is indicated for the treatment of iron overload in patients with thalassaemia major when current chelation therapy is contraindicated or inadequate.deferiprone lipomed in combination with another chelator is indicated in patients with thalassaemia major when monotherapy with any iron chelator is ineffective, or when prevention or treatment of life-threatening consequences of iron overload justifies rapid or intensive correction.

Thalidomide Lipomed European Union - English - EMA (European Medicines Agency)

thalidomide lipomed

lipomed gmbh - thalidomide - multiple myeloma - immunosuppressants - thalidomide lipomed in combination with melphalan and prednisone is indicated as first line treatment of patients with untreated multiple myeloma, aged ≥ 65 years or ineligible for high dose chemotherapy.thalidomide lipomed is prescribed and dispensed in accordance with the thalidomide lipomed pregnancy prevention programme (see section 4.4).

Carbocisteine  Labomed S.A. «sugar free» 750mg/5ml oral solution Malta - English - Medicines Authority

carbocisteine labomed s.a. «sugar free» 750mg/5ml oral solution

labomed pharmaceutical company s.a. 84 ioannou metaxa str. 19441, koropi attica, greece - oral solution - carbocisteine 750 mg - cough and cold preparations

Dacarbazine Lipomed 500 mg powder for solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

dacarbazine lipomed 500 mg powder for solution for infusion

lipomed gmbh - dacarbazine - powder for solution for infusion - 500 milligram(s) - other alkylating agents; dacarbazine

Dacarbazine Lipomed 1000 mg powder for solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

dacarbazine lipomed 1000 mg powder for solution for infusion

lipomed gmbh - dacarbazine - powder for solution for infusion - 1000 milligram(s) - other alkylating agents; dacarbazine

Dacarbazine Lipomed 200 mg powder for solution for injection or infusion Ireland - English - HPRA (Health Products Regulatory Authority)

dacarbazine lipomed 200 mg powder for solution for injection or infusion

lipomed gmbh - dacarbazine - powder for solution for injection/infusion - 200 milligram(s) - other alkylating agents; dacarbazine

RECK-Technik MOTOmed layson Singapore - English - HSA (Health Sciences Authority)

reck-technik motomed layson

optimal medical products pte ltd - physical medicine - motomed is intended exclusively for passive, assistive and active movement of the lower and upper extremities of persons in a supine position.

Motomed viva 2 motorized movement therapy system Singapore - English - HSA (Health Sciences Authority)

motomed viva 2 motorized movement therapy system

optimal medical products pte ltd - physical medicine - motorized movement therapy system for physically disabled people, mainly for wheelchair users. therapy goals of the motomed: 1. reducing spasticity, becoming more flexible 2. rediscovering residual muscle strength 3. counteracting the consequences of a lack of movement 4. promoting walking ability

Motomed gracile motorized movement therapy system Singapore - English - HSA (Health Sciences Authority)

motomed gracile motorized movement therapy system

optimal medical products pte ltd - physical medicine - motorized movement therapy system for children with special needs, mainly for wheelchair users. therapy goals of the motomed: 1. reducing spasticity, becoming more flexible 2. rediscovering residual muscle strength 3. counteracting the consequences of a lack of movement 4. promoting walking ability

Motomed letto 2 motorized movement therapy system Singapore - English - HSA (Health Sciences Authority)

motomed letto 2 motorized movement therapy system

optimal medical products pte ltd - physical medicine - motorized movement therapy system for patients confined to bed. goals of the motomed: 1. reducing spasticity, becoming more flexible 2. rediscovering residual muscle strength 3. counteracting the consequences of a lack of movement 4. promoting walking ability